Related Experiment Video
Updated: Aug 20, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Precision medicine: Ray of hope in overcoming cancer multidrug resistance
Pankaj Musyuni1, Jing Bai2, Afsana Sheikh3
1Centre for Advanced Formulation and Technology (CAFT), Delhi Pharmaceutical Sciences and Research University, Pushp Vihar, Govt. of NCT of Delhi, New Delhi 110017, India.
Abstract:
Multi-drug resistance (MDR) developed in response to chemotherapy is one of the prominent causes of therapeutic failure. The major underlying factors that contribute to such malignancies include tumor microenvironment, genetic alterations, changes at the cellular level and most of all the heterogeneity of tumors. Recent advances in the field of oncology have prompted a mechanistic understanding of the human genome which is responsible for such alterations, upon which the therapy would be designed. Such an approach that administers drugs by targeting the molecular changes is attributed to precision medicine. Precision medicine helps design therapy as per the requirement of patients based on the sharing of similar complex tumor environments. This revolutionized approach would help in early detection, better targeting, improved patient compliance and survival along with much reduced toxicity otherwise evidenced in conventional cancer therapy. This review discusses the cause of MDR, highlighting the role of precision medicine in overcoming such critical events. Major limitations and future prospects are also highlighted.
Insights
Multi-drug resistance (MDR) in cancer therapy leads to treatment failure. Precision medicine offers a targeted approach to overcome MDR by tailoring treatments to individual tumor molecular profiles, improving outcomes.
Area of Science:
- Oncology
- Genomics
- Pharmacology
Background:
- Multi-drug resistance (MDR) is a primary cause of chemotherapy failure.
- Tumor microenvironment, genetic alterations, cellular changes, and tumor heterogeneity contribute to MDR.
- Understanding the human genome is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To discuss the causes of MDR in cancer.
- To highlight the role of precision medicine in overcoming MDR.
- To review the limitations and future prospects of precision medicine in oncology.
Main Methods:
- Review of current literature on MDR and precision medicine.
- Analysis of molecular mechanisms underlying tumor resistance.
- Exploration of precision medicine strategies in oncology.
Main Results:
- Precision medicine enables therapy design based on individual molecular alterations and tumor environments.
- This approach facilitates early detection, targeted treatment, and improved patient survival.
- Precision medicine can reduce the toxicity associated with conventional chemotherapy.
Conclusions:
- Precision medicine represents a revolutionary approach to cancer therapy, particularly in overcoming MDR.
- Further research is needed to address limitations and fully realize the potential of precision medicine.
- Personalized therapeutic strategies hold significant promise for improving cancer treatment efficacy and patient care.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer